Raze Therapeutics
discovers and develops oncology therapeutics that target fundamental metabolic pathways driving cancer growth and survival... Read moreRaze Therapeutics
discovers and develops oncology therapeutics that target fundamental metabolic pathways driving cancer growth and survival... Read more
Interim-CEO
Jason Rhodes
News
Oct 01, 2015
BIOPORTFOLIO
Raze Therapeutics: Raze Therapeutics
May 28, 2015
BIOSPACE
Raze Therapeutics: Raze Therapeutics Announces Addition Of To Scientific Advisory Board
May 28, 2015
BUSINESS WIRE
Press Release: Raze Therapeutics : Raze Therapeutics Announces Addition of Robert Copeland, PhD, to Scientific Advisory Board
Apr 07, 2015
BIOSPACE
Raze Therapeutics: Raze Therapeutics Appoints As Chief Scientific Officer
Apr 07, 2015
BUSINESS WIRE
Press Release: Raze Therapeutics : Raze Therapeutics Appoints Mark Manfredi as Chief Scientific Officer
Jan 07, 2015
BIOSPACE
Raze Therapeutics: Raze Therapeutics Announces Addition Of And To Scientific Advisory Board
Jan 07, 2015
BUSINESS WIRE
Press Release: Raze Therapeutics : Raze Therapeutics Announces Addition of Julian Adams, PhD, George Q. Daley, MD, PhD, and Karen Vousden, PhD, to Scientific Advisory Board
Oct 28, 2014
BIOSPACE
Raze Therapeutics: Raze Therapeutics Appoints As Vice President, Molecular Discovery
Oct 28, 2014
BUSINESS WIRE
Press Release: Raze Therapeutics : Raze Therapeutics Appoints Mikel Moyer, PhD, as Vice President, Molecular Discovery
Oct 22, 2014
4-TRADERS
Raze Therapeutics: Raze Therapeutics Launches with $24 Million Series A Financing to Advance a New Class of Oncology Therapeutics Targeting Metabolic Pathways Essential...
Raze Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10